February 22, 2013

The Food and Drug Administration has approved a new treatment for late-stage breast cancer, the agency said.

March 30, 2012

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.